On Friday, February 8, 2013, the Lurie Cancer Center and Northwestern University Feinberg School of Medicine will host the Breast Cancer Review: Updates from the 2012 San Antonio Breast Cancer Symposium. The review is a comprehensive summary of the most up-to-date research and clinical data presented at the recent San Antonio Breast Cancer Symposium.
Friday, February 8, 2013: 2:00 p.m. – 5:00 p.m.
A reception will take place immediately following the symposium.
Prentice Women's Hospital
250 E. Superior St., Chicago
3rd floor, Conference Room L
William J. Gradishar, MD, FACP
Betsy Bramsen Professorship of Breast Oncology
Director, Maggie Daley Center for Women's Cancer Care
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Northwestern University Feinberg School of Medicine
| 2:00 p.m. – 2:05 p.m. |
Opening Remarks
|
|
| 2:05 p.m. - 3:00 p.m.
|
Advanced Disease
William J. Gradishar, MD, FACP
Betsy Bramsen Professor of Breast Oncology
Director, Maggie Daley Center For Women's Cancer Care
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
|
|
| 3:00 p.m. – 3:45 p.m.
|
Local Therapy Update
Seema A. Khan MD
Director, Bluhm Family Program for Breast Cancer Early Detection and Prevention
|
|
| 3:45 p.m. – 4:00 p.m. |
Break |
|
| 4:00 p.m. – 4:45 p.m.
|
Adjuvant and Neoadjuvant Therapy
Virginia G. Kaklamani, MD, DSc
Associate Professor, Division Hematology/Oncology
Director, Translational Breast Cancer Research
Co-Director Cancer Genetics Program
|
|
| 4:45 p.m. – 5:00 p.m. |
Closing Remarks & Discussion
William J. Gradishar, MD, FACP
|
|
| 5:00 p.m. – 5:30 p.m. |
Reception |
|
Not an official event of the San Antonio Breast Cancer Symposium.
Target Audience
Medical, surgical, and radiation oncologists, oncology specialty pharmacists, and other translational-oriented laboratory scientists charged with the care of patients with breast cancer. Also nurses, pharmacists, physician assistants, and other health care professionals involved in clinical cancer care and cancer research.
Conference Objectives
1. Discuss emerging data on and recent advances in the treatment of patients with breast cancer and integrate key findings into clinical practice.
2. Describe the potential role of novel treatment approaches in the management of breast cancer.
3. Compare treatment options available for the treatment of patients with breast cancer with respect to efficacy and toxicity parameters.
Accreditation Statement
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 2.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Faculty Disclosure
Northwestern University Feinberg School of Medicine requires course directors, speakers, instructors, planners and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by NUFSM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. The faculty disclosures and the discussion off-label usage will be indicated in the course syllabus.
Exhibitors
The following companies provided an exhibit display fee:
- Amgen, Inc.
- Celgene Corporation
- Eisai, Inc.
- Genentech USA, Inc.
- Genomic Health, Inc.
- Novartis Oncology
|
|
